Cambridge Healthtech Institute’s 8th Annual

RNA-Targeted Small Molecule Drug Discovery

Novel Strategies Using Small Molecules to Target RNA Structure, Binding, Interactions, and Function

April 19, 2027


RNA molecules have complex, dynamic structures which make them challenging drug targets. However, advances in elucidating RNA structure, function, and interactions have led to finding small molecules to target RNA for therapeutic intervention. AI models and machine learning algorithms have also helped predict RNA-ligand interactions and optimize compounds with enhanced stability, oral bioavailability, and better drug-like properties. However, identifying the right disease-causing RNA and evaluating the downstream physiological responses after small molecule binding can be quite challenging. Cambridge Healthtech Institute’s symposium on RNA-Targeted Small Molecule Drug Discovery will highlight some of the early discovery and preclinical work being done to target mRNA, non-coding RNA, microRNA, and other modalities for cardiometabolic, infectious, and neurologic disorders, oncology, and other genetic indications.

Coverage will likely include:

  • Identifying and targeting the right RNA structural motifs and binding sites for therapeutic intervention
  • Screening tools for characterization and optimization of the RNA modulators, binders, and degraders
  • Tools for validating RNA structural accessibility, functional modulation, and disease association
  • Developing new RNA splicing modulators, covalent inhibitors, RNA degraders, and proximity inducers
  • Targeting RNA-protein binding interactions
  • Using AI and machine learning to design and predict RNA-ligand binding and modulation

The deadline for priority consideration is October 5, 2026.

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

Opportunities for Participation:


For more details on the conference, please contact:
Tanuja Koppal, PhD
Senior Conference Director
Cambridge Healthtech Institute
Email: tkoppal@healthtech.com

For sponsorship information, please contact:
Kristin Skahan
Senior Business Development Manager
Cambridge Healthtech Institute
Phone: (+1) 781-972-5431
Email: kskahan@healthtech.com


Register Early for Maximum Savings

APRIL 19

Covalent & Induced Proximity-Based Therapies

RNA-Modulating Small Molecule Drugs

Generative AI for Drug Discovery

training seminars

View In-Person Short Courses

APRIL 20 - 21

Degraders & Molecular Glues - Part 1

Small Molecule Discovery Technologies

AI/ML for Early Drug Discovery - Part 1

Linker & Conjugation Chemistries

Peptides

APRIL 21 - 22

Degraders & Molecular Glues - Part 2

Protein-Protein Interactions / Difficult Targets

AI/ML for Early Drug Discovery - Part 2

DNA-Encoded Libraries

GLP1 & Oral Peptides


Drug Discovery Chemsitry Europe

View All Sponsors

View All Media Partners